Put Options

23 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $5.17 Million - $6.53 Million
77,700 Added 1295.0%
83,700 $7.02 Million
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $328,380 - $378,976
5,200 Added 650.0%
6,000 $411,000
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $1.39 Million - $1.69 Million
-19,400 Reduced 96.04%
800 $58,000
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $1.25 Million - $1.43 Million
-16,500 Reduced 44.96%
20,200 $1.56 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $15.3 Million - $17.4 Million
-197,500 Reduced 84.33%
36,700 $3.04 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $1.23 Million - $1.77 Million
19,800 Added 9.24%
234,200 $20.1 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $11 Million - $12.5 Million
-184,500 Reduced 46.25%
214,400 $13.2 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $4.13 Million - $4.65 Million
71,600 Added 21.88%
398,900 $24.7 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $115,840 - $145,160
2,000 Added 0.61%
327,300 $19.5 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $7.52 Million - $8.53 Million
115,900 Added 55.35%
325,300 $23.6 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $21.8 Million - $23.5 Million
-321,900 Reduced 60.59%
209,400 $14.6 Million
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $2.87 Million - $3.13 Million
-45,200 Reduced 7.84%
531,300 $36.6 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $20.1 Million - $22.9 Million
-334,700 Reduced 36.73%
576,500 $37.3 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $19.7 Million - $22.5 Million
-348,600 Reduced 27.67%
911,200 $53.1 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $38.5 Million - $48.4 Million
619,900 Added 96.87%
1,259,800 $79.6 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $22.6 Million - $26.2 Million
-311,800 Reduced 32.76%
639,900 $49.2 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $24.4 Million - $31.2 Million
389,100 Added 69.16%
951,700 $71.1 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $17.2 Million - $18.9 Million
279,100 Added 98.45%
562,600 $36.6 Million
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $2.48 Million - $2.74 Million
39,700 Added 16.28%
283,500 $18 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $10.8 Million - $12.1 Million
-174,400 Reduced 41.7%
243,800 $16.5 Million
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $3.9 Million - $4.37 Million
62,400 Added 17.54%
418,200 $27.2 Million
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $1.77 Million - $2.31 Million
-29,300 Reduced 7.61%
355,800 $22.3 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $27.4 Million - $30.4 Million
385,100 New
385,100 $29.7 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.